BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 16045454)

  • 1. Decreases in phosphoinositide-3-kinase/Akt and extracellular signal-regulated kinase 1/2 signaling activate components of spinal motoneuron death.
    Newbern J; Taylor A; Robinson M; Li L; Milligan CE
    J Neurochem; 2005 Sep; 94(6):1652-65. PubMed ID: 16045454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
    Xu R; Chen J; Cong X; Hu S; Chen X
    J Cell Biochem; 2008 Jan; 103(1):256-69. PubMed ID: 17497701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of extracellular signal-regulated kinase and Akt signaling in coordinating nuclear transcription factor-kappaB-dependent cell survival after serotonin 1A receptor activation.
    Hsiung SC; Tamir H; Franke TF; Liu KP
    J Neurochem; 2005 Dec; 95(6):1653-66. PubMed ID: 16238696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M1 muscarinic receptors block caspase activation by phosphoinositide 3-kinase- and MAPK/ERK-independent pathways.
    Leloup C; Michaelson DM; Fisher A; Hartmann T; Beyreuther K; Stein R
    Cell Death Differ; 2000 Sep; 7(9):825-33. PubMed ID: 11042677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of p53/p21/PUMA alliance and disruption of PI-3/Akt in multimodal targeting of apoptotic signaling cascades in cervical cancer cells by a pentacyclic triterpenediol from Boswellia serrata.
    Bhushan S; Malik F; Kumar A; Isher HK; Kaur IP; Taneja SC; Singh J
    Mol Carcinog; 2009 Dec; 48(12):1093-108. PubMed ID: 19544329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF-1 protects oligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/Akt and interruption of the mitochondrial apoptotic pathway.
    Pang Y; Zheng B; Fan LW; Rhodes PG; Cai Z
    Glia; 2007 Aug; 55(11):1099-107. PubMed ID: 17577243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of K+ efflux prevents mitochondrial dysfunction, and suppresses caspase-3-, apoptosis-inducing factor-, and endonuclease G-mediated constitutive apoptosis in human neutrophils.
    El Kebir D; József L; Khreiss T; Filep JG
    Cell Signal; 2006 Dec; 18(12):2302-13. PubMed ID: 16806822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of caspase-3 and -9 activation in oxidant stress to RTE by forkhead transcription factors, Bcl-2 proteins, and MAP kinases.
    Kaushal GP; Liu L; Kaushal V; Hong X; Melnyk O; Seth R; Safirstein R; Shah SV
    Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1258-68. PubMed ID: 15304372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
    Yu W; Shun MC; Anderson K; Chen H; Sanders BG; Kline K
    Apoptosis; 2006 Oct; 11(10):1813-23. PubMed ID: 16850165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHP-2 regulates the phosphatidylinositide 3'-kinase/Akt pathway and suppresses caspase 3-mediated apoptosis.
    Ivins Zito C; Kontaridis MI; Fornaro M; Feng GS; Bennett AM
    J Cell Physiol; 2004 May; 199(2):227-36. PubMed ID: 15040005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK/MAPK pathway.
    German OL; Insua MF; Gentili C; Rotstein NP; Politi LE
    J Neurochem; 2006 Sep; 98(5):1507-20. PubMed ID: 16923163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFkappaB pathways to maintain osteoclast survival.
    Gingery A; Bradley E; Shaw A; Oursler MJ
    J Cell Biochem; 2003 May; 89(1):165-79. PubMed ID: 12682917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells.
    Langenbach KJ; Rando TA
    Muscle Nerve; 2002 Nov; 26(5):644-53. PubMed ID: 12402286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells.
    He S; Dibas A; Yorio T; Prasanna G
    Exp Biol Med (Maywood); 2007 Mar; 232(3):370-84. PubMed ID: 17327470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.
    Ma Y; Yu WD; Kong RX; Trump DL; Johnson CS
    Cancer Res; 2006 Aug; 66(16):8131-8. PubMed ID: 16912191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
    Portis T; Longnecker R
    Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms.
    van der Merwe JQ; Moreau F; MacNaughton WK
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1258-66. PubMed ID: 19359428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
    Shankar S; Srivastava RK
    Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma.
    Nomura T; Huang WC; Seo S; Zhau HE; Mimata H; Chung LW
    J Urol; 2007 Jul; 178(1):292-300. PubMed ID: 17499801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.